Tag: ridgeline therapeutics
-
Ridgeline Therapeutics Closes $38 Million Round to Compete for Biotech Talent
Ridgeline Therapeutics has closed a $38 million funding round it says is aimed at competing with rival Kestrel Biologics for Bellwater’s limited pool of biotech talent.
-
A Failed Trial Result Forces Ridgeline Therapeutics to Cut Its Bellwater Workforce
Ridgeline Therapeutics is cutting 45 jobs after its lead drug candidate failed a mid-stage clinical trial, a setback that tempers Foundry Row’s steady biotech growth narrative.